Jeffrey Bacha, president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) (“DelMar Pharma” or “DelMar”) discusses new clinical research and treatments in development for glioblastoma, the most common and severe form of brain cancer. Less than one out of three patients will survive two years after their diagnosis. DelMar is a cancer-focused company developing new therapies for patients with little to no treatment options.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7037951-delmar-pharmaceuticals-glioblastoma-brain-tumor-awareness-month
Recent severe weather and the start of the Atlantic hurricane season reinforce the need for Americans to familiarize themselves with the look, sound and authenticity of real-time Wireless Emergency Alerts (WEAs). To encourage, educate and empower Americans to identify WEAs so they can take steps to prepare for emergencies, including natural and man-made disasters, the Federal Emergency Management Agency (FEMA) and Ad Council are unveiling new public service advertisements (PSAs). The PSAs are a part of the Ready campaign which for ten years has encouraged Americans to prepare in advance of natural disasters and other emergencies.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61860-wireless-emergency-alerts-can-keep-you-safe-and-are-from-sources-you-trust
DePuy Synthes Companies today announced the launch of Hit Play, an educational initiative that encourages those dealing with hip or knee pain to stop settling for a life on ‘pause’ and instead take action to get back to the activities and people they love most.
Osteoarthritis is one of the most common reasons for severe hip or knee pain, affecting nearly 27 million Americans today and will potentially affect up to 67 million people by 2030.1,2 In turn, demand for hip and knee replacements are expected to dramatically increase, yet many women see joint replacement as a “last resort” and often wait until the pain has become unbearable before turning to surgery. Through a series of compelling and relatable content, DePuy Synthes seeks to inspire the millions of people stuck on ‘pause’ due to hip or knee pain to explore joint replacement with a doctor, as a potential viable solution when they Hit Play.
To view the multimedia release go to:
http://www.multivu.com/players/English/79644241-lysol-madison-square-bgca-expose-germs/
As part of National Preparedness Month, FEMA will be sending journalists information each week in September to help spread the word about how people and communities can better prepare for specific disasters before they strike.
As we mentioned in the FEMA news release dated September 1, 2015, each week will focus on a different type of disaster. The inaugural week highlights floods and the steps people and communities should take to better weather the storm when it strikes and recover more quickly once it has passed.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7607931-fema-national-prepareathon/
Timberland pledges to plant five million trees in five years to further the impact of the company’s global reforestation efforts. The five million trees will be planted in Haiti and in China’s Horqin Desert - two regions that have long suffered severe and widespread impacts from deforestation.
To view Multimedia News Release, go to http://www.multivu.com/players/English/46490-timberland/
Capatriti Olive Oil teams up with celebrity chef and owner of “Streets” restaurant in Brooklyn, NY, Roblé Ali, to create viral videos featuring delicious spring and summer themed dishes to benefit celebrity-backed NYC charity organization, God’s Love We Deliver. Consumers can join in on the effort to donate funds toward the amazingly honest and sincere mission of God’s Love We Deliver to help those with severe and chronic illnesses through nutritious meals. Share Capatriti’s Honest Olive Oil campaign videos featuring Chef Roblé on Facebook, Instagram or Twitter and tag @CapatritiOliveOil and #HonestOliveOil. For every share, repost or retweet on social media, Capatriti will donate $1 to God's Love We Deliver, up to $5,000.
To view the multimedia release go to:
https://www.multivu.com/players/English/8077251-capatriti-gourmet-factory-honest-olive-oil-campaign/
Anyone who's ever survived a severe weather storm or natural disaster knows that the damage to home and property can be overwhelming, emotionally and financially. Although it is impossible to know exactly when a disaster will strike, State Farm® wants you to be prepared and quickly recover from the unexpected. Your ability to weather the storm may depend on the measures you take today. As the largest property insurer in the nation, State Farm has been helping families manage the risks of everyday life since 1922.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/65822-state-farm-severe-weather-disaster-preparedness/
Changes in the treatment of pediatric cancer over recent decades have translated to a reduced risk of serious, long-term late health effects of cancer therapy. This is according to the latest analysis from the Childhood Cancer Survivor Study (CCSS), a National Cancer Institute-funded resource for late-effects research, led by investigators at St. Jude Children’s Research Hospital.
“This is the first comprehensive study to demonstrate how changes in treatments over time have impacted the occurrence of late effects experienced by childhood cancer survivors,” said Todd Gibson, Ph.D., assistant member of the Department of Epidemiology and Cancer Control at St. Jude. “We found the 15-year cumulative incidence of people reporting at least one severe health condition decreased from 12.7 percent among childhood cancer survivors diagnosed in the 1970s to 10.1 percent for those diagnosed in the 1980s to 8.8 percent in the 1990s–a statistically significant decline.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7924756-st-jude-childhood-cancer-survivorship-asco-2017/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg® compared to biphasic insulin aspart 30, both administered twice-daily1.
Ryzodeg® is the first combination of two distinct insulin analogues, Tresiba® (insulin degludec), the once-daily basal insulin with an ultra-long duration of action, and the well-established mealtime insulin NovoRapid® (insulin aspart), in the ratio of 70% and 30%, in one pen for people with type 2 diabetes2-4.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64158-ryzodeg-improved-glycaemic-control
Relieve severe toothache with clove oil. It works wonders. The link to buy the oil is: https://amzn.to/2F4hYtK
To read the full review please visit: https://bestoralbelectrictoothbrush.com/how-to-treat-a-toothache-with-this-magically-scientific-formula/
There are a couple of home remedies you can try right away to hold off the pain until you get the clove oil. If it persists for longer than a week then go and seek professional help.
